Cognition in multiple sclerosis: Between cognitive reserve and brain volume

Aging and Cognitive FunctionsMultiple Sclerosis

Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures

J Neurol.

Santangelo G, Bisecco A, Trojano L, Sacco R, Siciliano M, d'Ambrosio A, Della Corte M, Lavorgna L, Bonavita S, Tedeschi G, Gallo A

doi: 10.1007/s00415-018-8905-9.

Multiple Sclerosis

Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment

J Neurol.

Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M

doi: 10.1007/s00415-018-9139-6.

Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Brain

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J

doi: 10.1093/brain/awy154.

RECOMMENDED

Multiple Sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Eur Neurol.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö

doi: 10.1159/000495798.

Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

J Neuroinflammation.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI

doi: 10.1186/s12974-018-1295-1.

Multiple Sclerosis

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Brain.

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP

doi: 10.1093/brain/aww258.

Aging and Cognitive FunctionsMultiple Sclerosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

J Neurol.

Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group

doi: 10.1007/s00415-017-8642-5.

RECOMMENDED

Aging and Cognitive FunctionsMultiple Sclerosis

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Brain.

Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O

doi: 10.1093/brain/awz156.

Aging and Cognitive FunctionsMultiple Sclerosis

Recommendations for cognitive screening and management in multiple sclerosis care

Mult Scler.

Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J

doi: 10.1177/1352458518803785.

Related content

Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures

Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Recommendations for cognitive screening and management in multiple sclerosis care